Australia
Ellex Medical Lasers Limited (ASX:ELX), a global leader in medical devices for the diagnosis and treatment of eye disease, today reported its sales for the 4 months to 31 October 2018 to shareholders at the Company Annual General Meeting.
AusCann appoints TGA licensed PCI Pharma to manufacture and release its first medicinal cannabis product line.
One company, Life Biosciences, is taking a broad—yet also specific—approach to longevity and diseases of aging. Co-founder and chairman David Sinclair took time to talk to BioSpace about the company.
Even with the Thanksgiving week, there is interesting and exciting research being conducted and published. Here’s a look.
Development, licence and supply agreement for treatment of migraine in US market
New research published in The Journal of Physiology identifies a novel protein that reduces the likelihood of obesity and related metabolic disorders in boys.
Regeneus Ltd is pleased to announce John Martin, CEO, will present at the AusBiotech 2018 Conference today.
The Hydroponics Company Limited, to be renamed THC Global Group Limited is pleased to provide an update to the market of its activities for the quarter ended 30 September 2018 (the Quarter).
Nanollose Limited is pleased to provide its Appendix 4C cash flow statement for the quarter ending 30 September 2018, together with the following operational update.
Anatara Lifesciences is pleased to release its Appendix 4C for the quarter ending 30th September 2018. The Company’s cash position at the end of the quarter stood at $7.1m.
PRESS RELEASES